The OECD Program to Validate the Rat Hershberger Bioassay to Screen Compounds for in Vivo Androgen and Antiandrogen Responses: Phase 2 Dose–Response Studies
2007

Validation of the Hershberger Bioassay for Androgen and Antiandrogen Screening

Sample size: 41 publication Evidence: high

Author Information

Author(s): William Owens, Gray L. Earl Jr., Errol Zeiger, Michael Walker, Kanji Yamasaki, John Ashby, Elard Jacob

Primary Institution: Procter & Gamble

Hypothesis

Can the Hershberger bioassay reliably identify weak androgenic and antiandrogenic substances?

Conclusion

The OECD Hershberger bioassay protocol is reproducible and transferable across laboratories for detecting androgenic and antiandrogenic activities.

Supporting Evidence

  • The study involved 41 separate experiments across 16 laboratories.
  • The protocols were able to detect significant weight changes in androgen-responsive tissues.
  • The results were consistent across different experimental conditions.

Takeaway

This study tested a method to see if it can find chemicals that affect male hormones, and it worked well in many labs.

Methodology

The study involved 16 laboratories testing the Hershberger bioassay with various androgenic and antiandrogenic substances across different conditions.

Potential Biases

Variability in laboratory techniques and animal handling could introduce bias.

Limitations

Some laboratories had high variability in tissue handling, which affected results.

Participant Demographics

Sixteen laboratories from seven countries participated.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1289/ehp.9666

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication